miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR

Ji, L; Lin, ZJ; Wan, Z; Xia, SJ; Jiang, S; Cen, D; Cai, LX; Xu, JJ; Cai, XJ

Xu, JJ; Cai, XJ (corresponding author), Zhejiang Univ, Sch Med, Key Lab Laparoscop Technol Zhejiang Prov, Dept Gen Surg,Sir Run Run Shaw Hosp, Hangzhou 310016, Peoples R China.

CELL DEATH & DISEASE, 2020; 11 (4):

Abstract

HCC is a common malignancy worldwide and surgery or reginal treatments are deemed insufficient for advanced-stage disease. Sorafenib is an inhibitor o......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索